首页> 外文会议>World Pain Clinic Congress >Postoperative pain control - an update.
【24h】

Postoperative pain control - an update.

机译:术后疼痛控制 - 更新。

获取原文

摘要

Postoperative pain therapy is very important for the patients because an insufficient pain control can cause several negative reactions and jeopardise the health of patients. Insufficient postoperative pain therapy can result in a surgical stress reaction, deep vein thrombosis, coronary ischaemia, pulmonary embolism, and poor wound healing. Due to pain the proper respiratory function may be deteriorated, leading to some pulmonary complications, such as atelectasis and pneumonia. Psychological consequences including anxiety and depression may also be encountered. Although acute postoperative pain management has improved significantly in the past decades, inadequate postoperative pain relief remains a worldwide problem. Therefore, some efforts are ongoing to improve postoperative pain management. This therapy including "old" modalities of intermittent analgesic administration via i.m, s.c., and i.v. injections, continuous i.v. infusion has been improved already long time ago by using the PCA (patient-controlled analgesia) modalities either by intravenous or epidural routes. If appropriate, peripheral nerve or neuraxial blocks may be also used. Nevertheless some new therapy modalities have been recently developed and are under investigations or are already established. They include continuous wound infiltration with a local anaesthetic using an elastomeric infusion pump, morphine sulfate sustained-release liposome epidural injection, and intranasal/inhalational administration of opioids.
机译:术后疼痛治疗对于患者来说非常重要,因为止痛性不足可能导致几种负面反应并危及患者的健康。术后疼痛治疗不足可能导致手术应力反应,深静脉血栓形成,冠状动脉缺血,肺栓塞和伤口愈合不良。由于疼痛,适当的呼吸功能可能会恶化,导致一些肺部并发症,例如Atelectasis和肺炎。也可能遇到包括焦虑和抑郁症的心理后果。虽然在过去的几十年中,急性术后疼痛管理显着提高,但术后疼痛救济不足仍然是全球问题。因此,一些努力正在进行改善术后疼痛管理。这种治疗包括通过I.M,S.C.和I.v的“旧”镇痛给药的“旧”方式。注射,连续I.v.通过使用静脉内或硬膜外线的PCA(患者控制的镇痛)方式已经很久以来已经改善了输注。如果合适,也可以使用外周神经或神经障碍物。然而,最近已经开发了一些新的治疗方式,并正在调查或已经建立。它们包括使用弹性体输液泵的局部麻醉剂,使用弹性体输液泵,吗啡硫酸盐缓释的脂质体注射液,以及阿片类药物的鼻内/吸入施用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号